Skip to main content

Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

 

CTD²
Molecular Cancer Therapeutics

Researchers screened a panel of non-small cell lung cancer cell lines for chemical sensitivity and identified SW044248, a topoisomerase I inhibitor.

CTD²
Nature Medicine

Researchers demonstrate that SWI/SNF-mutant cancer cells are primarily dependent on a non-catalytic role of EZH2 in the stabilization of the PRC2 complex, and that they are only partially dependent on EZH2 histone methyltransferase activity.

CTD²
Cancer Discovery

Epigenetic regulator RNF2 has a dual role in tumorigenesis and metastasis of melanomas.

TARGET
Nature Communications

Researchers discovered mutations in the MLLT1 gene in Wilms tumor that might help explain Wilms tumor development.

CTD²
Cancer Research

Investigators used large-scale genomics to separate driver and passenger mutations and learn more about the functionality of driver mutations.

CTD²
Nature Medicine

Researchers compared whole-exome sequencing of matched benign, malignant and metastatic skin tumors to study the evolution of metastasis.

CTD²
Nature Medicine

Researchers used bioinformatics tools to detect heterogeneity within tumors in The Cancer Genome Atlas.

CTD²
Genome Medicine

The authors developed a web interface to allow the linkage of genetic information from The Cancer Genome Atlas with associated clinical data.

CTD²
Cancer Research

The researchers used an algorithm to identify drivers of the transformation from follicular lymphoma to diffuse large B-cell lymphoma

CTD²
Journal of Molecular Cell Biology

Researchers created a high-throughput method for identifying protein-protein interactions in live cells